In line with induction of energy expenditure by bile acids, lowering of the bile acid pool via treatment with the FXR-agonist GW4064 was shown to result in decreased energy expenditure, weight gain and insulin resistance [14]. Here, NR1H4 is linked to Insulin resistance.